271 related articles for article (PubMed ID: 29402636)
1. Elimination of lymphatic filariasis in west African urban areas: is implementation of mass drug administration necessary?
Koudou BG; de Souza DK; Biritwum NK; Bougma R; Aboulaye M; Elhassan E; Bush S; Molyneux DH
Lancet Infect Dis; 2018 Jun; 18(6):e214-e220. PubMed ID: 29402636
[TBL] [Abstract][Full Text] [Related]
2. Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria.
Pam DD; de Souza DK; D'Souza S; Opoku M; Sanda S; Nazaradden I; Anagbogu IN; Okoronkwo C; Davies E; Elhassan E; Molyneux DH; Bockarie MJ; Koudou BG
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006004. PubMed ID: 29020042
[TBL] [Abstract][Full Text] [Related]
3. Community-based trial of annual versus biannual single-dose ivermectin plus albendazole against Wuchereria bancrofti infection in human and mosquito populations: study protocol for a cluster randomised controlled trial.
de Souza DK; Ahorlu CS; Adu-Amankwah S; Otchere J; Mensah SK; Larbi IA; Mensah GE; Biritwum NK; Boakye DA
Trials; 2017 Oct; 18(1):448. PubMed ID: 28969715
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of a triple-drug regimen for global elimination of lymphatic filariasis: a modelling study.
Irvine MA; Stolk WA; Smith ME; Subramanian S; Singh BK; Weil GJ; Michael E; Hollingsworth TD
Lancet Infect Dis; 2017 Apr; 17(4):451-458. PubMed ID: 28012943
[TBL] [Abstract][Full Text] [Related]
5. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL
Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363
[TBL] [Abstract][Full Text] [Related]
6. Geographic and ecologic heterogeneity in elimination thresholds for the major vector-borne helminthic disease, lymphatic filariasis.
Gambhir M; Bockarie M; Tisch D; Kazura J; Remais J; Spear R; Michael E
BMC Biol; 2010 Mar; 8():22. PubMed ID: 20236528
[TBL] [Abstract][Full Text] [Related]
7. Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators.
Jambulingam P; Subramanian S; de Vlas SJ; Vinubala C; Stolk WA
Parasit Vectors; 2016 Sep; 9(1):501. PubMed ID: 27624157
[TBL] [Abstract][Full Text] [Related]
8. Effect of 3 years of biannual mass drug administration with albendazole on lymphatic filariasis and soil-transmitted helminth infections: a community-based study in Republic of the Congo.
Pion SDS; Chesnais CB; Weil GJ; Fischer PU; Missamou F; Boussinesq M
Lancet Infect Dis; 2017 Jul; 17(7):763-769. PubMed ID: 28372977
[TBL] [Abstract][Full Text] [Related]
9. Elimination of lymphatic filariasis: do we have the drugs to complete the job?
Bockarie MJ; Deb RM
Curr Opin Infect Dis; 2010 Dec; 23(6):617-20. PubMed ID: 20847694
[TBL] [Abstract][Full Text] [Related]
10. Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes.
Bockarie MJ; Alexander ND; Hyun P; Dimber Z; Bockarie F; Ibam E; Alpers MP; Kazura JW
Lancet; 1998 Jan; 351(9097):162-8. PubMed ID: 9449870
[TBL] [Abstract][Full Text] [Related]
11. Increasing evidence of low lymphatic filariasis prevalence in high risk Loa loa areas in Central and West Africa: a literature review.
Kelly-Hope LA; Hemingway J; Taylor MJ; Molyneux DH
Parasit Vectors; 2018 Jun; 11(1):349. PubMed ID: 29907117
[TBL] [Abstract][Full Text] [Related]
12. Lymphatic filariasis elimination efforts in Rufiji, southeastern Tanzania: decline in circulating filarial antigen prevalence in young school children after twelve rounds of mass drug administration and utilization of long-lasting insecticide-treated nets.
Jones C; Ngasalla B; Derua YA; Tarimo D; Malecela MN
Int J Infect Dis; 2017 Aug; 61():38-43. PubMed ID: 28527817
[TBL] [Abstract][Full Text] [Related]
13. Reassessment of areas with persistent Lymphatic Filariasis nine years after cessation of mass drug administration in Sri Lanka.
Rao RU; Samarasekera SD; Nagodavithana KC; Dassanayaka TDM; Punchihewa MW; Ranasinghe USB; Weil GJ
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006066. PubMed ID: 29084213
[TBL] [Abstract][Full Text] [Related]
14. Toward the elimination of lymphatic filariasis by 2020: treatment update and impact assessment for the endgame.
Rebollo MP; Bockarie MJ
Expert Rev Anti Infect Ther; 2013 Jul; 11(7):723-31. PubMed ID: 23879610
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of effectiveness of diethylcarbamazine/albendazole combination in reduction of Wuchereria bancrofti infection using multiple infection parameters.
Wamae CN; Njenga SM; Ngugi BM; Mbui J; Njaanake HK
Acta Trop; 2011 Sep; 120 Suppl 1():S33-8. PubMed ID: 20933491
[TBL] [Abstract][Full Text] [Related]
16. Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
Fischer PU; King CL; Jacobson JA; Weil GJ
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005163. PubMed ID: 28056015
[No Abstract] [Full Text] [Related]
17. Fifteen years of programme implementation for the elimination of Lymphatic Filariasis in Ghana: Impact of MDA on immunoparasitological indicators.
Biritwum NK; de Souza DK; Marfo B; Odoom S; Alomatu B; Asiedu O; Yeboah A; Hervie TE; Mensah EO; Yikpotey P; Koroma JB; Molyneux D; Bockarie MJ; Gyapong JO
PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005280. PubMed ID: 28333930
[No Abstract] [Full Text] [Related]
18. Surveillance for transmission of lymphatic filariasis in Colombo and Gampaha districts of Sri Lanka following mass drug administration.
Chandrasena NT; Premaratna R; Samarasekera DS; de Silva NR
Trans R Soc Trop Med Hyg; 2016 Dec; 110(10):620-622. PubMed ID: 27816936
[TBL] [Abstract][Full Text] [Related]
19. Situation analysis in a large urban area of India, prior to launching a programme of mass drug administrations to eliminate lymphatic filariasis.
Ramaiah KD; Vijay Kumar KN; Ravi R; Das PK
Ann Trop Med Parasitol; 2005 Apr; 99(3):243-52. PubMed ID: 15829134
[TBL] [Abstract][Full Text] [Related]
20. A triple-drug treatment regimen to accelerate elimination of lymphatic filariasis: From conception to delivery.
Weil GJ; Jacobson JA; King JD
Int Health; 2020 Dec; 13(Suppl 1):S60-S64. PubMed ID: 33349879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
